IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q1 2018 Holdings

Filed 2018-05-15 | 7 holdings | $133.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arsanis IncCOM042873109$42.8K1,868,96132.1%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$34.4K1,716,30325.8%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$24.5K2,579,49018.3%
Transenterix IncCOM NEW89366M201$12.8K7,546,6929.6%
Ocular Therapeutix Inc(OCUL)COM67576A100$10.4K1,605,2077.8%
Catabasis Pharmaceuticals inCOM14875P107$5.2K2,857,6673.9%
Reshape Life Sciences IncCOM761123108$3.3K2,250,9582.4%